Using low-dose octreotide with diazoxide-resistant congenital hyperinsulinism resulting from compound heterozygous mutations in the ABCC8 gene.
作者信息
Park Kyujung, Lim Kyung In, Sohn Young Bae, Lee Hae Sang, Hwang Jin Soon
机构信息
Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea.
出版信息
Ann Pediatr Endocrinol Metab. 2023 Dec;28(Suppl 1):S23-S24. doi: 10.6065/apem.2244068.034. Epub 2022 Jun 29.
Abstract
摘要
相似文献
1
Using low-dose octreotide with diazoxide-resistant congenital hyperinsulinism resulting from compound heterozygous mutations in the ABCC8 gene.将低剂量奥曲肽用于治疗由ABCC8基因复合杂合突变导致的对二氮嗪耐药的先天性高胰岛素血症。
Ann Pediatr Endocrinol Metab. 2023 Dec;28(Suppl 1):S23-S24. doi: 10.6065/apem.2244068.034. Epub 2022 Jun 29.
2
Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.ABCC8 复合杂合突变导致的先天性高胰岛素血症对二氮嗪治疗有反应。
J Pediatr Endocrinol Metab. 2020 May 26;33(5):671-674. doi: 10.1515/jpem-2019-0457.
3
Novel Compound Heterozygous Variants of the Gene Warrant Identification of Pancreatic Histology in Infant with Diazoxide-unresponsive Congenital Hyperinsulinism.基因的新型复合杂合变异体有助于鉴定二氮嗪无反应性先天性高胰岛素血症婴儿的胰腺组织学。
Children (Basel). 2021 Sep 23;8(10):836. doi: 10.3390/children8100836.
4
A novel case of compound heterozygous congenital hyperinsulinism without high insulin levels.一例无高胰岛素水平的复合杂合子先天性高胰岛素血症的新病例。
Int J Pediatr Endocrinol. 2015;2015(1):16. doi: 10.1186/s13633-015-0012-4. Epub 2015 Jul 15.
5
Congenital hyperinsulinism: clinical and molecular characterisation of compound heterozygous ABCC8 mutation responsive to Diazoxide therapy.先天性高胰岛素血症：对二氮嗪治疗有反应的复合杂合子ABCC8突变的临床和分子特征
Int J Pediatr Endocrinol. 2014;2014(1):24. doi: 10.1186/1687-9856-2014-24. Epub 2014 Dec 15.
6
A Newborn with Congenital Hyperinsulinism.一名患有先天性高胰岛素血症的新生儿。
Fetal Pediatr Pathol. 2019 Oct;38(5):406-411. doi: 10.1080/15513815.2019.1603255. Epub 2019 Apr 19.
7
Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation.一名因纯合子ABCC8突变导致高胰岛素血症的新生儿对二氮嗪部分反应。
Endocrinol Diabetes Metab Case Rep. 2019 Feb 11;2019. doi: 10.1530/EDM-18-0120.
8
Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism.鉴定韩国先天性高胰岛素血症患者中 ABCC8 和 KCNJ11 基因突变与表型的关系。
Eur J Endocrinol. 2011 Jun;164(6):919-26. doi: 10.1530/EJE-11-0160. Epub 2011 Mar 21.
9
Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time.因K-ATP通道基因突变而接受保守治疗的先天性高胰岛素血症（CHI）：随着时间推移严重程度降低。
Orphanet J Rare Dis. 2016 Dec 1;11(1):163. doi: 10.1186/s13023-016-0547-3.
10
Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China.中国南方先天性高胰岛素血症患儿的临床管理与基因突变分析
J Clin Res Pediatr Endocrinol. 2019 Nov 22;11(4):400-409. doi: 10.4274/jcrpe.galenos.2019.2019.0046. Epub 2019 Jun 18.
本文引用的文献
1
Congenital hyperinsulinism: recent updates on molecular mechanisms, diagnosis and management.先天性高胰岛素血症：分子机制、诊断和治疗的最新进展。
J Pediatr Endocrinol Metab. 2021 Sep 21;35(3):279-296. doi: 10.1515/jpem-2021-0369. Print 2022 Mar 28.
2
Congenital Hyperinsulinism: Diagnosis and Treatment Update.先天性高胰岛素血症：诊断与治疗的最新进展
J Clin Res Pediatr Endocrinol. 2017 Dec 30;9(Suppl 2):69-87. doi: 10.4274/jcrpe.2017.S007. Epub 2017 Dec 27.
3
Congenital Hypoglycemia Disorders: New Aspects of Etiology, Diagnosis, Treatment and Outcomes: Highlights of the Proceedings of the Congenital Hypoglycemia Disorders Symposium, Philadelphia April 2016.先天性低血糖症：病因、诊断、治疗及预后的新进展：2016年4月于费城召开的先天性低血糖症研讨会会议纪要要点
Pediatr Diabetes. 2017 Feb;18(1):3-9. doi: 10.1111/pedi.12453. Epub 2016 Oct 18.
4
Congenital hyperinsulinism: current trends in diagnosis and therapy.先天性高胰岛素血症：诊断与治疗的现状趋势。
Orphanet J Rare Dis. 2011 Oct 3;6:63. doi: 10.1186/1750-1172-6-63.
5
Glycemic response to glucagon during fasting hypoglycemia: an aid in the diagnosis of hyperinsulinism.空腹低血糖时对胰高血糖素的血糖反应：对高胰岛素血症诊断的辅助作用。
J Pediatr. 1980 Feb;96(2):257-9. doi: 10.1016/s0022-3476(80)80817-1.
Zotero 插件